UBS maintains Viant Technology at Buy, lowers price target to $18 from $19

UBS kept its Buy rating on Viant Technology but reduced its price target from $19 to $18, a 5.3% cut. This new target suggests a 28.2% upside from the Nov 9 closing price of $14.04.

Original reporting
Published Nov 10, 2026, 8:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UBS maintains Viant Technology at Buy, lowers price target to $18 from $19 — source image
Decision brief

The 30-second read

Low
01

Why it matters

The downgrade may trigger short-term selling but long-term fundamentals remain unchanged.

02

Market read

Analyst target cut provides a modest trading signal for VNT.

03

What to watch

Potential upside from upcoming contract announcements not reflected in the target.

Relevance 5/10Novelty 5/10Timing: today

Background

Viant Technology is a small-cap AI infrastructure provider; analyst coverage is limited.

Market effects

Minimal impact on the broader tech sector.

Limited to U.S. small-cap investors.

Low

Counterpoint

The target cut may be overly cautious; the stock could rebound if upcoming product milestones succeed.

Key entities

  • UBS

    Maintains Buy rating but reduces price target.

Related articles

Med

Viant net income drops 49% in record quarter as revenue gains 29%

Viant Technology reported Q3 2026 revenue up 29% to $110.4M, but net income fell 49% to $2.6M. Contribution ex-TAC and adjusted EBITDA beat guidance. The company acquired Waymark for $20M and expanded integrations with AI platforms. Healthcare and public services drove growth, with CTV spend exceeding 50% of total platform spend.

Med

Viant Technology (DSP) Q3 2026 Earnings Call Transcript

Viant Technology (DSP) reported Q3 2026 earnings with revenue up 29% YoY, exceeding guidance. CTV advertiser spend rose 40% YoY. Adjusted EBITDA increased 24% to $19.8M. The company acquired Waymark, a generative AI video platform, to enhance CTV ad capabilities. Viant's proprietary intelligence and AI solutions drove growth across verticals.

$DSPMed

Viant Technology Inc (DSP) (Q3 2026) Earnings Call Highlights: Revenue Surges 29% as CTV

Viant Technology (DSP) reported Q3 2026 revenue of $110.4M, up 29% YoY, exceeding guidance. CTV advertiser spend grew 40% YoY, contributing over 50% of total platform spend. Adjusted EBITDA rose 24% to $19.8M. The company acquired Waymark for AI video creative production, but open internet traffic decline and slow TVision adoption were noted as risks. Q4 guidance projects revenue of $130.5M-$133.5M, up 20% at midpoint.

$DSPMed

Viant Technology Q3 Earnings Call Highlights

Viant Technology reported a 41% rise in spending enabled by IRIS Content ID. Its autonomous advertising product, Outcomes, was used by over 10% of advertisers, with top 10 advertisers allocating 26% of their spending to it. The company integrated its platform with AI interfaces and launched TVision Mobile Meter. Viant forecasted Q4 revenue of $130.5M-$133.5M and adjusted EBITDA of $31M-$32M. It also increased its share repurchase authorization by $50M.

$DSPMed

Viant Q3 2026 slides: CTV surge drives record revenue, margins

Viant Technology (DSP) reported Q3 2026 revenue of $110.4M, up 29% YoY, with adjusted EBITDA of $19.8M (29% margin). CTV demand drove growth, with CTV spend exceeding 50% of total advertiser spend. Shares rose 9.3% pre-market but fell 7.1% after-hours. Q4 guidance projects $132M revenue (20% YoY growth) and $31.5M adjusted EBITDA (39% margin).

$DSPHigh

Viant Technology Announces Third Quarter 2026 Financial Results

Viant Technology Inc. (DSP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Viant Technology Announces Third Quarter 2026 Financial Results Revenue increased 29% year-over-year Gross profit increased 30% year-over-year Contribution ex-TAC increased 27% year-over-year Adjusted EBITDA increased 24% year-over-year Increased share repurchase aut